Skip to main
KDNY
KDNY logo

Chinook Therapeutics (KDNY)

$0.00

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

Buy Chinook Therapeutics (KDNY) Stock

About Chinook Therapeutics (KDNY)

Chinook Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in discovering, developing, and commercializing precision medicines for rare, severe chronic kidney diseases. The company was founded in 2019 and is headquartered in Seattle, WA.
Market cap$2.9B
Today's volume
Revenue (TTM)
Avg. daily volume1.91M
EBITDA (TTM)
Open
Price / earnings ratio-11.49x
Today's range
Debt / equity
52 week range$18.34 - $40.51
5 year debt / equity15.27x
Beta (LTM)1.05x
Interest coverage
Dividend & yield$0.00 (0.00%)
Current ratio
Ex-dividend date
Next earningsNov 5, 2020
Dividend payable date

Chinook Therapeutics Stock Rating

What analysts recommend for KDNY stock, on a scale from 1(buy) to 5(sell).
Hold
Strong Buy 0%
Buy 20%
Hold 80%
Sell 0%
Strong Sell 0%

Frequently Asked Questions (FAQ)

As of Jun 21, 2025, the market cap for KDNY stock is $2.91B

The current P/E ratio for KDNY stock is -11.49

The 52-week high for KDNY stock is $40.51. The current KDNY stock price $undefined is 100.00% below its 52-week high

The 52-week low for KDNY stock is $18.34. The current KDNY stock price $undefined has increased 100.00% from its 52-week low

No, the KDNY stock does not pay dividends to its shareholders

The target price for KDNY stock is $39.80 based on the average of what a group of analyst think KDNY stock could be worth at a future date. This is not a prediction by Public.com

How to buy KDNY stock on Public

  1. 1

    Sign up for a brokerage account on Public

    It’s easy to get started. You can sign up for an account directly on our website or by downloading the Public app for iOS or Android.

  2. 2

    Add funds to your Public account

    There are multiple ways to fund your Public account—from linking a bank account to making a deposit with a debit card or wire transfer.

  3. 3

    Choose how much you'd like to invest in KDNY stock

    Navigate to the Explore page. Then, type KDNY into the search bar. When you see KDNY stock appear in the results, tap it to open up the purchase screen.

  4. 4

    Manage your investments in one place

    You can find your newly purchased KDNY stock in your portfolio—alongside the rest of your stocks, ETFs, crypto, treasuries, and alternative assets.

Chinook Therapeutics Stock Earnings

The value each KDNY share was expected to gain vs. the value that each KDNY share actually gained.

Chinook Therapeutics (KDNY) reported earnings per share (EPS) of $0, estimates of $0 by . In the same quarter last year, Chinook Therapeutics's earnings per share (EPS) was $0. Chinook Therapeutics is expected to release next earnings on 11/05/2020, with an earnings per share (EPS) estimate of $0.

Buy Chinook Therapeutics (KDNY) Stock

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.